-
COPD Treatment Landscape
David Orchard-Webb
January 19, 2024
The comprehensive management of Chronic Obstructive Pulmonary Disease (COPD) requires a multi-faceted approach encompassing medications, lifestyle adjustments, and surgical interventions.
-
Pharma and Biotech Review: Treatment Options for COVID-19: Decoding the Latest Developments
Neeta Ratanghayra
March 11, 2020
The Coronavirus Disease 2019 (COVID-19), which emerged in Wuhan, a city of 11 million in Hubei province, has spread to more than two dozen countries, taking the lives of more than 2,800 people.
-
Postop Anxiety During Care Transitions Reduced With Peer Mentoring
drugs.com
January 28, 2022
Mentoring programs can help improve patients' transition from hospital to home by reducing...
-
FDA Grants Emergency Use Authorization for Pfizer's Paxlovid Pill as First At-Home COVID-19 Treatment
drugs
December 22, 2021
he U.S. Food and Drug Administration on Wednesday approved the emergency use of Pfizer's new antiviral pill Paxlovid in people who are at high risk for severe COVID-19. It's the first approved treatment for COVID-19 meant to be taken at home.
-
Evive Biotech meets primary and secondary endpoints in global Phase III clinical trial for their novel chemotherapy-induced neutropenia treatment
prnasia
July 08, 2020
Evive Biotech, a global biologics company developing novel biological therapies, is delighted to announce that its pivotal Phase III study (NCT03252431) for F-627 (efbemalenograstim alpha) to treat chemotherapy-induced neutropenia (CIN) in breast cancer
-
Vice-premier stresses research on COVID-19 vaccine, treatment, medicine
chinadaily
April 04, 2020
Vice-Premier Sun Chunlan on April 1 stressed making full use of the effective drugs and treatment technologies and accelerating the progress of vaccine research and development to fight the novel coronavirus disease (COVID-19).
-
FDA continues to facilitate development of COVID-19 treatments
worldpharmanews
March 23, 2020
The U.S. Food and Drug Administration continues to play a critical role in the multifaceted all-of-government response to the COVID-19 pandemic.
-
Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments
prnewswire
March 20, 2020
The U.S. Food and Drug Administration continues to play a critical role in the multifaceted all-of-government response to the COVID-19 pandemic.
-
High-dose Erythropoietin No Benefit for Extreme Preemies
drugs
January 20, 2020
For extremely preterm infants, high-dose erythropoietin treatment from 24 hours after birth does not result in a reduced risk for severe neurodevelopmental impairment or death at age 2 years ...
-
SinuSonic Clinical Trial Data Shows Safety and Efficacy for Nonpharmacologic Device
americanpharmaceuticalreview
December 30, 2019
Healthy Humming has announced positive topline data from a prospective outcomes study, which assessed the safety and efficacy of the SinuSonic ...